Trademark: 97337754
Word
RADD PHARMACEUTICALS
Status Date
Wednesday, October 18, 2023
Filing Date
Wednesday, March 30, 2022
Published for Opposition
Tuesday, February 28, 2023
42 Medical and scientific research in the field of oncology and cancer treatment; Pharmaceutical research and development; Research and development in the field of oncology and cancer treatment
The mark consists of the wording "RADD PHARMACEUTICALS" in stylized lettering to the left of which is a representation of a helicase consisting of a circular band of smaller shaded ovals, wrapping around a Y-shaped representation of double stranded DNA unwinding into two single strands.
"PHARMACEUTICALS"
Oct 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 18, 2023
Sou Extension 1 Granted
Oct 18, 2023
Sou Extension 1 Filed
Oct 18, 2023
Sou Teas Extension Received
Apr 25, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 28, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2023
Published For Opposition
Feb 8, 2023
Notification Of Notice Of Publication E-Mailed
Jan 20, 2023
Approved For Pub - Principal Register
Jan 19, 2023
Examiner's Amendment Entered
Jan 19, 2023
Notification Of Examiners Amendment E-Mailed
Jan 19, 2023
Examiners Amendment E-Mailed
Jan 19, 2023
Examiners Amendment -Written
Jan 17, 2023
Assigned To Examiner
Apr 5, 2022
Notice Of Design Search Code E-Mailed
Apr 4, 2022
New Application Office Supplied Data Entered
Apr 2, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
